Detailed price information for Abacus Global Management Inc (ABL-Q) from The Globe and Mail including charting and trades.

Currently approved therapies for amyotrophic lateral sclerosis (ALS) — a progressive neurodegenerative disease characterized by loss of motor neurons — exhibit limited effectiveness. By screening a ...

Abacus Global Management, Inc. operates as an alternative asset manager and market maker in the United States. It operates in five segments: Active Management, Originations, Asset Management, ...

ABL Bio receives USD 40 mn upfront payment for license, research and collaboration agreement for Grabody platform and equity investment from Eli Lilly: Seoul, South Korea Monday, ...

ABL’s acquisition of SCF Containers deepens its presence in Australia’s container and intermodal logistics markets.

Abacus Global Management, Inc. ( NASDAQ:ABL ) shareholders will doubtless be very grateful to see the share price ...

A California company that has yet to even attempt a rocket launch has nonetheless inked a major deal with Lockheed Martin for dozens of missions over the next decade. Under terms of the block-buy ...

ABL Space Systems is looking to raise up to $100 million in new funding, and has just closed over $40 million, according to a new filing with the U.S. Securities and Exchange Commission. The company ...

ABL Diagnostics (Euronext: ABLD - ISIN: FR001400AHX6) informs its shareholders and the market that Advanced Biological Laboratories S.A. ("ABL S.A."), its controlling shareholder, and ProPhase Labs, ...